Marshall Wace
USPH icon

Marshall Wace’s US Physical Therapy USPH Stock Holding History

Marshall Wace’s Portfolio USPH Stock Details USPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.7M Buy
68,453
+42,890
+168% +$2.91M ﹤0.01% 1410
2026
Q1 		$1.92M Buy
25,563
+17,845
+231% +$1.46M ﹤0.01% 1809
2025
Q4 		$603K Sell
7,718
-37,098
-83% -$3.01M ﹤0.01% 2172
2025
Q3 		$3.81M Buy
44,816
+16,479
+58% +$1.32M ﹤0.01% 1302
2025
Q2 		$2.22M Sell
28,337
-12,612
-31% -$930K ﹤0.01% 1509
2025
Q1 		$2.96M Sell
40,949
-3,585
-8% -$301K ﹤0.01% 1296
2024
Q4 		$3.95M Buy
44,534
+1,591
+4% +$142K ﹤0.01% 1166
2024
Q3 		$3.63M Buy
42,943
+7,551
+21% +$670K ﹤0.01% 1120
2024
Q2 		$3.27M Buy
35,392
+378
+1% +$38.2K ﹤0.01% 1162
2024
Q1 		$3.95M Sell
35,014
-24,450
-41% -$2.44M 0.01% 1094
2023
Q4 		$5.54M Sell
59,464
-56,297
-49% -$4.96M 0.01% 875
2023
Q3 		$10.6M Buy
115,761
+21,003
+22% +$2.26M 0.02% 636
2023
Q2 		$11.5M Buy
+94,758
New +$10.2M 0.02% 670
2022
Q4 		– Sell
-11,155
Closed -$847K – 3444
2022
Q3 		$847K Buy
+11,155
New +$1.07M ﹤0.01% 2479
2022
Q2 		– Sell
-13,956
Closed -$1.39M – 3881
2022
Q1 		$1.39M Sell
13,956
-39,869
-74% -$3.8M ﹤0.01% 2290
2021
Q4 		$5.14M Buy
+53,825
New +$5.4M 0.01% 1333
2021
Q2 		– Sell
-12,103
Closed -$1.26M – 3117
2021
Q1 		$1.26M Buy
+12,103
New +$1.51M 0.01% 1542
2019
Q2 		– Sell
-292
Closed -$31K – 1864
2019
Q1 		$31K Sell
292
-320
-52% -$34.4K ﹤0.01% 1592
2018
Q4 		$63K Buy
+612
New +$67.9K ﹤0.01% 1425
2016
Q3 		– Sell
-4,778
Closed -$288K – 1148
2016
Q2 		$288K Sell
4,778
-10,286
-68% -$564K ﹤0.01% 903
2016
Q1 		$749K Buy
+15,064
New +$749K 0.01% 771

Other funds holding USPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
SAM
Southernsun Asset Management Memphis, Tennessee $743M AUM 34.03% 1-Year Est. Return

Marshall Wace's USPH Position: Q2 2026 in Review

Marshall Wace increased its US Physical Therapy (USPH) stake by 168% in Q2 2026, buying an estimated $2.91M and bringing the position to 68,453 shares worth $4.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1410.

Marshall Wace first reported a position in USPH in Q1 2016 and has held it in 21 quarters since. The position peaked at $11.5M in Q2 2023. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Marshall Wace held 68,453 shares of US Physical Therapy worth $4.7M as of Q2 2026.
  • Marshall Wace bought 42,890 US Physical Therapy shares in Q2 2026, an estimated $2.91M.
  • US Physical Therapy made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1410 holding.
  • Marshall Wace first reported a position in US Physical Therapy in Q1 2016 and has held it in 21 quarters since.
  • Marshall Wace's US Physical Therapy position peaked at $11.5M in Q2 2023.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.